This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 323006
Submitted by lobbyist on: June 21, 2013 10:47:34 AM
Accepted by Registrar on: June 24, 2013 12:36:19 PM
Designated Filer Information
| Dawson, Robert W |
| 17300 Trans-Canada Highway | |
|
Kirkland, QC, H9J 2M5
|
250-472-7601 |
| Canada |
Organization Information
| Pfizer Canada |
| Pfizer Inc. is one of the world's leading research based pharmaceutical companies. Pfizer discovers and develops life-saving and life-enhancing medications for humans. The company's Canadian operation, Pfizer Canada Inc., is one of the largest private contributors to health research in Canada and also donates millions of dollars annually to support community initiatives. Headquartered in Montreal, Quebec, Pfizer Canada and its cross-Canada team are working together for a healthier world. Pfizer Canada's commitment to helping Canadians live happier, healthier and longer lives extends beyond medication. |
| 17300 Trans-Canada Highway | |
|
Kirkland, QC, H9J 2M5
|
250-472-7601 |
| Canada |
Relevant Affiliates
Type:
| Business Name | Mailing Address | Contact Information |
|---|---|---|
| Pfizer Inc. |
235 East 42nd Street
New York, NY 10017 United States of America |
Phone: 212-573-2323 |
Government or Government Agency Funding
Other Controlling or Directing Interests
Active Registration Period
| June 21, 2013 | |
| January 25, 2014 |
Organization's In-House Lobbyists
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
To represent Pfizer commercial operations with Government Officials, and brief Ministry of Health staff on Pfizer Canada's key priorities and health care investments in the Province. To gain insights from the Ministry on their challenges and medium/long term public policy priorities.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Staff of Minister | Minister of Health | January 10, 2014 | |
| Minister | Lake, Terry | Minister of Health | June 21, 2013 |
| Minister | Stilwell, Michelle | Parliamentary Secretary for Healthy Living to the Min. of Health | June 21, 2013 |
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
To represent Pfizer medicines and policies and answer questions specific to the pharmaceutical industry and/or Pfizer Canada's business activities in the Province, as well as learn more about the health policy priorites of the Official Opposition.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| MLA | Darcy, Judy | New Westminster | June 21, 2013 |
Health
Development, establishment, amendment or termination of any program, policy or decision
Meet, review and discuss drug submission files (as determined appropriate by staff) within the Pharmaceutical Services Division (Ministry of Health)on Pfizer medications or vaccines. Respond to any concerns or questions regarding a Pfizer pharmaceutical medicine or policy.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | June 21, 2013 | |
| Public Agency | Provincial Health Services Authority | June 21, 2013 |
Science and Technology
Arranging meeting between an individual and a public office holder for purpose of lobbying
To seek new partnerships in science and technology, and help foster an environment that supports innovation and increased medical research investment.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Letnick, Norm | Parliamentary Secretary to the Premier for Intergovernmental Affairs | June 21, 2013 |
| Minister | Wilkinson, Andrew | Minister of Technology, Innovation and Citizens' Services | June 21, 2013 |